Emeritus
Mayo Clinic
Scottsdale, Arizona, United States
Monika Lecomte Gloviczki, MD, PhD, is a Research Fellow and Research Collaborator Emeritus, Department of Internal Medicine and Gonda Vascular Center, Mayo Clinic, Rochester, MN. She has current affiliation at VASA LLC in Scottsdale, AZ. She graduated from the Faculty of Medicine in Paris (France)- CHU Necker-Enfants Malades, where she earned MD and PhD titles. She obtained a master’s degree in Statistic Methodology and Statistics in Clinical Research at the University Pierre and Marie Curie in Paris. She also completed a Fellowship and Board certification in Phlebology, at the Faculty of Medicine - CHU Pitié Salpetrière.
Dr. Gloviczki worked for 15 years at Servier Laboratories on the research studies involving Micronized Purified Flavonoid Fraction (MPFF) and new drugs for venous and lymphatic disorders. She was a leader of large international studies (RELIEF...), observational and double-blind randomized studies in venous insufficiency, venous ulcers, and lymphedema, and the pharmacovigilance committee. With Pr. Bergan, she started the “International Venous Digest by Fax”. She edited a series of Atlas of Veins and Lymphatics and launched the journal Phlebolymphology.
In 2007, she joined Mayo Clinic in Rochester, where she worked as a Research Fellow and Research Collaborator of the Gonda Vascular Center, and received the Mayo Clinic Department of Medicine Outstanding Research Fellow Award. Her research included the epidemiology of venous ulcers in Olmsted County. Author/co-author of several publications/books’ chapters, she was Assistant Editor of the 3rd/4th Edition of the Handbook of Venous and Lymphatic Disorders, and currently an Associate Editor for the 5th Edition of the Handbook. She is an active member and Distinguished Fellow of the AVF, and served in the Venous Ulcer Guidelines, Lymphedema and Varicose Vein Guidelines Committees. Dr. Gloviczki is also Honorary Member of the French College of Vascular Pathology and Honorary Member of Polish Society for Vascular Surgery.
Disclosure information not submitted.
Utility of Venoactive Compounds in Postthrombotic Syndrome – Systematic Review
Tuesday, March 5, 2024
3:15 PM – 4:45 PM EST